Journal
/
Bioengineering
/
CRISPR-Cas Synthetic Urine Biomarker Test for Cancer Diagnostics…
/
암 진단을 위한 나노센서 특성화 및 CRISPR-Cas 매개 소변 바이오마커…
JoVE Journal
Bioengineering
Bioengineering
A subscription to JoVE is required to view this content. Sign in or start your free trial.
암 진단을 위한 나노센서 특성화 및 CRISPR-Cas 매개 소변 바이오마커 검사
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/201254-v
•
03:23 min
•
December 8th, 2023
암 진단을 위한 나노센서 특성화 및 CRISPR-Cas 매개 소변 바이오마커 검사
CRISPR-Cas Synthetic Urine Biomarker Test for Cancer Diagnostics
December 8th, 2023
•
Audrey E. Van Heest1, Feiyang Deng1, Renee T. Zhao2, Nour Saida Harzallah2,3, Heather E. Fleming3,4, Sangeeta N. Bhatia2,3,4,5,6,7,8, Liangliang Hao1,2,3
1Department of Biomedical Engineering, Boston University, 2Institute for Medical Engineering and Science, Massachusetts Institute of Technology, 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 4Howard Hughes Medical Institute, 5Broad Institute of Massachusetts Institute of Technology and Harvard, 6Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 7Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 8Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
